About genedx holdings corp - WGS
GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
WGS At a Glance
GeneDx Holdings Corp.
North Tower
Stamford, Connecticut 06902
| Phone | 1-888-729-1206 | Revenue | 427.54M | |
| Industry | Medical/Nursing Services | Net Income | -21,021,000.00 | |
| Sector | Health Services | 2025 Sales Growth | 39.97% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,300 | |
| View SEC Filings |
WGS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 8.713 |
| Price to Book Ratio | 12.342 |
| Price to Cash Flow Ratio | 111.94 |
| Enterprise Value to EBITDA | 273.21 |
| Enterprise Value to Sales | 8.577 |
| Total Debt to Enterprise Value | 0.031 |
WGS Efficiency
| Revenue/Employee | 328,876.154 |
| Income Per Employee | -16,170.00 |
| Receivables Turnover | 5.749 |
| Total Asset Turnover | 0.826 |
WGS Liquidity
| Current Ratio | 2.463 |
| Quick Ratio | 2.335 |
| Cash Ratio | 1.573 |
WGS Profitability
| Gross Margin | 65.098 |
| Operating Margin | -2.76 |
| Pretax Margin | -4.944 |
| Net Margin | -4.917 |
| Return on Assets | -4.062 |
| Return on Equity | -7.597 |
| Return on Total Capital | -4.989 |
| Return on Invested Capital | -5.457 |
WGS Capital Structure
| Total Debt to Total Equity | 36.721 |
| Total Debt to Total Capital | 26.858 |
| Total Debt to Total Assets | 19.847 |
| Long-Term Debt to Equity | 33.818 |
| Long-Term Debt to Total Capital | 24.735 |